close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

314.52 -5.86 (-1.83%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024. 
Via Investor's Business Daily
High growth, ROE and relative strength for NASDAQ:PODD, growth investors may appreciate this.
Evaluating INSULET CORP (NASDAQ:PODD) for Growth Investment Opportunities. 
Via Chartmill
Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency1)
From Insulet Corporation
Via Business Wire
9 Analysts Have This To Say About Insulet
 
Via Benzinga
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
 
Via Benzinga
Why NASDAQ:PODD qualifies as a high growth stock.
Is INSULET CORP (NASDAQ:PODD) suited for high growth investing? 
Via Chartmill
(PODD) - Analyzing Insulet's Short Interest
 
Via Benzinga
Here's How Much $1000 Invested In Insulet 10 Years Ago Would Be Worth Today
 
Via Benzinga
Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November
From Insulet Corporation 
Via Business Wire
Omnipod® 5 App for iPhone® Now Fully Available in the United States
From Insulet Corporation
Via Business Wire
Is NASDAQ:PODD on the Verge of a Major Breakout as a Strong Growth Stock?
Why INSULET CORP (NASDAQ:PODD) Is a Standout High-Growth Stock in a Consolidation Phase. 
Via Chartmill
Solventum Stock Earns 81 RS Rating
Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81. 
Via Investor's Business Daily
If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today
 
Via Benzinga
Analyst Ratings For Insulet
 
Via Benzinga
Is NASDAQ:PODD a Fit for high Growth Investing Strategies?
Is INSULET CORP (NASDAQ:PODD) suited for high growth investing? 
Via Chartmill
Exploring the Growth Potential of NASDAQ:PODD as It Nears a Breakout.
Why INSULET CORP (NASDAQ:PODD) Is a Promising High-Growth Stock in the Midst of Consolidation. 
Via Chartmill
Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
From Insulet Corporation
Via Business Wire
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
 
Via Benzinga
Analyst Expectations For Insulet's Future
 
Via Benzinga
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today
 
Via Benzinga
(PODD) - Analyzing Insulet's Short Interest
 
Via Benzinga
Here's How Much You Would Have Made Owning Insulet Stock In The Last 10 Years
 
Via Benzinga
Upstart, Insulet And 2 Other Stocks Executives Are Selling
 
Via Benzinga
Affirm, Mongodb And Best Buy Are Among Top 10 Large Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
Top-performing large-cap stocks from last week: AFRM, NTNX, MDB, BBY, GEV, TCOM, COO, PODD, VEEV, AZPN. 
Via Benzinga
Why Insulet Stock Was Zooming Higher This Week
The company had encouraging news to impart about its leading insulin pump. 
Via The Motley Fool
Stocks To Watch Today: PODD, SMCI, And PAYC
Insulet Corporation surged on FDA approval for its diabetes treatment device, while SMCI faced pressure from a short-seller report, and Paycom Software saw insider selling activity. 
Via Talk Markets
Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes
From Insulet Corporation
Via Business Wire
S&P 500, Nasdaq 100 Snap 8-Day Winning Streak: What Triggered Wall Street's Setback On Tuesday?
S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the latest. 
Via Benzinga
Topics Stocks
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today